The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kotov A.S.

Vladimirsky Moscow Regional Research Clinical Institute

Novikova E.S.

Moscow Regional Research and Clinical Institute («MONIKI»)

Metkechekova Yu.V.

Vladimirsky Moscow Regional Research Clinical Institute

Clinical polymorphism of demyelinating diseases associated with MOG-antibodies

Authors:

Kotov A.S., Novikova E.S., Metkechekova Yu.V.

More about the authors

Read: 1581 times


To cite this article:

Kotov AS, Novikova ES, Metkechekova YuV. Clinical polymorphism of demyelinating diseases associated with MOG-antibodies. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12):95‑101. (In Russ.)
https://doi.org/10.17116/jnevro202012012195

Recommended articles:
Personality profile caused by epilepsy acco­rding to the «Big Five» model. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):16-21
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Ototoxicity caused by anti-epileptic drugs. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):14-19
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40
Abse­nce status epilepticus in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):47-56
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30

References:

  1. Kezuka T, Ishikawa H. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis. Jpn J Ophthalmol. 2018;62(2):101-108.  https://doi.org/10.1007/s10384-018-0561-1
  2. Dos Passos GR, Oliveira LM, da Costa BK, et al. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder. Front Neurol. 2018;9:217.  https://doi.org/10.3389/fneur.2018.00217
  3. Weber MS, Derfuss T, Metz I, Brück W. Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord. 2018;11:1-15.  https://doi.org/10.1177/1756286418762083
  4. Fukushima N, Suzuki M, Ogawa R, et al. A case of anti-MOG antibody-positive multiphasic disseminated encephalomyelitis co-occurring with unilateral cerebral cortical encephalitis. Rinsho Shinkeigaku. 2017;57(11):723-728.  https://doi.org/10.5692/clinicalneurol.cn-001078
  5. Wang JJ, Jaunmuktane Z, Mummery C, et al. Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD. Neurology. 2016;87(2):229-231.  https://doi.org/10.1212/WNL.0000000000002844
  6. Kira JI. Unexpected exacerbations following initiation of disease-modifying drugs in neuromyelitis optica spectrum disorder: Which factor is responsible, anti-aquaporin 4 antibodies, B cells, Th1 cells, Th2 cells, Th17 cells, or others? Mult Scler. 2017;23(9):1300-1302. https://doi.org/10.1177/1352458517703803
  7. Ramanathan S, Reddel SW, Henderson A, et al. Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm. 2014;1(4):e40.  https://doi.org/10.1212/NXI.0000000000000040
  8. Reindl M, Jarius S, Rostasy K, Berger T. Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they? Curr Opin Neurol. 2017; 30(3):295-301.  https://doi.org/10.1097/WCO.0000000000000446
  9. Zhong X, Zhou Y, Chang Y, et al. Seizure and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis in a Retrospective Cohort of Chinese Patients. Front Neurol. 2019;10:415.  https://doi.org/10.3389/fneur.2019.00415
  10. Hamid SHM, Whittam D, Saviour M, et al. Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease. JAMA Neurol. 2018;75(1):65-71.  https://doi.org/10.1001/jamaneurol.2017.3196
  11. Gutman JM, Kupersmith M, Galetta S, Kister I. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in patients with optic neuritis and seizures. J Neurol Sci. 2018;387:170-173.  https://doi.org/10.1016/j.jns.2018.01.042
  12. Shchepareva ME, Kochergin IA, Tolpeeva OA, et al. Diagnosticheskoe znachenie antitel k mielin-oligodendrotsitarnomu glikoproteinu pri demieliniziruyushchikh zabolevaniyakh tsentral’noj nervnoj sistemy. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2019;119(2):18-23. (In Russ.). https://doi.org/10.17116/jnevro20191192218

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.